Richard Saynor
Richard Saynor is the CEO of Sandoz, a prominent generic pharmaceutical company. He has been at the forefront of navigating the challenges posed by changing economic policies, particularly in the U.S. market, where he aims to expand Sandoz's footprint despite recent production closures in the country.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Switzerland | 1 | 5.00 | 0.08% | +0% | 8,654,622 | 6,673 | $700,000 | 540$ |
| Totals | 1 | 8,654,622 | 6,673 | $700,000 | 540$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Richard Saynor warned that tariffs on generics would increase medication costs in the USA.
5
Switzerland:
Richard Saynor is the CEO of Sandoz, a Swiss generics manufacturer concerned about the declining prices of antibiotics due to competition from Chinese producers.
5
Switzerland:
Richard Saynor is the CEO of Sandoz and discusses the challenges and opportunities in the antibiotic market.
7
Switzerland:
Richard Saynor is the CEO of Sandoz and highlights the advantages of the Slovenian education system.
8
Canada:
Sandoz chief executive officer Richard Saynor said in a call with analysts Aug. 7 that the company plans to launch 'at some point during 2026.'
6
Switzerland:
Richard Saynor has been leading Sandoz since 2019 and is involved in discussions about medication pricing in the USA.
6
Switzerland:
Richard Saynor is the CEO of Sandoz, projecting a margin of approximately 21% for the current business year.
7
Slovenia:
Richard Saynor is the CEO of Sandoz and discussed the company's investment in Slovenia.
9
Switzerland:
Richard Saynor is the CEO of Sandoz and discussed the company's challenges at a press conference.
5